Purple Biotech appoints interim CEO
- Mr. Isaac Israel appointed as interim CEO effective 2026-10-05
- Mr. Gil Efron transitions to Executive Director, Head of Corporate Development
- Mr. Israel has served on the board since 2012
Every EDGAR filing for PURPLE BIOTECH LTD. (PPBT), newest first, with AI summaries and stories.
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
Ownership stake disclosure by SUSQUEHANNA SECURITIES, LLC (amended)
SUSQUEHANNA SECURITIES, LLC, filed by
Ownership stake disclosure by INTRACOASTAL CAPITAL, LLC (amended)
INTRACOASTAL CAPITAL, LLC, filed by
Simcha Rock, new insider at PPBT
Simcha Rock, reporting
Suzana Zilberberg, new insider at PPBT
Suzana Zilberberg, reporting
Ido Agmon, new insider at PPBT
Ido Agmon, reporting
Gil Efron, new insider at PPBT
Gil Efron, reporting
Shai S Lankry, new insider at PPBT (amended)
Shai S Lankry, reporting
Michael Schickler, new insider at PPBT
Michael Schickler, reporting
Shai S Lankry, new insider at PPBT
Shai S Lankry, reporting
Robert E. Gagnon, new insider at PPBT
Robert E. Gagnon, reporting
Ownership stake disclosure by SUSQUEHANNA SECURITIES, LLC
SUSQUEHANNA SECURITIES, LLC, filed by
Ownership stake disclosure by INTRACOASTAL CAPITAL, LLC (amended)
INTRACOASTAL CAPITAL, LLC, filed by